UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Protein tyrosine phosphatases in multiple myeloma

Cancer letters, 2021-03, Vol.501, p.105-113

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumour-agnostic drugs and future cancer treatment

Tidsskrift for den Norske Lægeforening, 2019-03, Vol.139 (5)

Børset, Magne

2019

Link zum Volltext

Verfügbarkeit prüfen

Why do myeloma patients have bone disease? A historical perspective

Blood reviews, 2020-05, Vol.41, p.100646-100646, Article 100646

2020

Link zum Volltext

Verfügbarkeit prüfen

Phosphatase of regenerating liver‐3 regulates cancer cell metabolism in multiple myeloma

The FASEB journal, 2021-03, Vol.35 (3), p.e21344-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Monitoring multiple myeloma by quantification of recurrent mutations in serum

Haematologica (Roma), 2017-07, Vol.102 (7), p.1266

2017

Link zum Volltext

Verfügbarkeit prüfen

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer

Translational oncology, 2020-01, Vol.13 (1), p.17-24

2020

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells

Molecules (Basel, Switzerland), 2021-12, Vol.26 (24), p.7447

2021

Link zum Volltext

Verfügbarkeit prüfen

Markers of endothelial glycocalyx dysfunction in Clarkson disease

Journal of translational medicine, 2022-08, Vol.20 (1), p.1-380, Article 380

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions

Cancers, 2021-04, Vol.13 (8), p.1788

2021

Link zum Volltext

Verfügbarkeit prüfen

PRL‐3 induces a positive signaling circuit between glycolysis and activation of STAT1/2

The FEBS journal, 2021-12, Vol.288 (23), p.6700-6715

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer

PloS one, 2017-11, Vol.12 (11), p.e0189000-e0189000

2017

Link zum Volltext

Verfügbarkeit prüfen

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Frontiers in immunology, 2021-02, Vol.12, p.636375-636375

2021

Link zum Volltext

Verfügbarkeit prüfen

Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3

Molecular cancer research, 2017-01, Vol.15 (1), p.69-77

2017

Link zum Volltext

Verfügbarkeit prüfen

Bronchoalveolar Lavage Fluid IFN-γ^+ Th17 Cells and Regulatory T Cells in Pulmonary Sarcoidosis

Mediators of Inflammation, 2014-01, Vol.2014 (4), p.438070-9

2014

Link zum Volltext

Verfügbarkeit prüfen

Anti-c-MET Nanobody® - a new potential drug in multiple myeloma treatment

European journal of haematology, 2013-11, Vol.91 (5), p.399-410

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting phosphoglycerate dehydrogenase in multiple myeloma

Experimental hematology & oncology, 2021-01, Vol.10 (1), p.3-3, Article 3

2021

Link zum Volltext

Verfügbarkeit prüfen

Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma

European journal of immunology, 2011-02, Vol.41 (2), p.437-449

2011

Link zum Volltext

Verfügbarkeit prüfen

Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?

European journal of haematology, 2022-07, Vol.109 (1), p.31-40

2022

Link zum Volltext

Verfügbarkeit prüfen

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

Oncotarget, 2015-09, Vol.6 (26), p.22698-22705

2015

Link zum Volltext

Verfügbarkeit prüfen

VOLIN and KJON-Two novel hyperdiploid myeloma cell lines

Genes chromosomes & cancer, 2016-11, Vol.55 (11), p.890-901

2016

Link zum Volltext

Verfügbarkeit prüfen

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Journal of hematology and oncology, 2016-08, Vol.9 (1), p.75-75, Article 75

2016

Link zum Volltext

Verfügbarkeit prüfen

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Blood, 2008-01, Vol.111 (2), p.806-815

2008

Link zum Volltext

Verfügbarkeit prüfen

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

Experimental hematology & oncology, 2018-04, Vol.7 (1), p.8-8, Article 8

2018

Link zum Volltext

Verfügbarkeit prüfen

Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration

European journal of haematology, 2013-09, Vol.91 (3), p.196-200

2013

Link zum Volltext

Verfügbarkeit prüfen

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance

Oncotarget, 2018-01, Vol.9 (3), p.3549-3561

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(118)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(77)
Humans
(67)
Hematology
(45)
Multiple Myeloma - Pathology
(36)
Biological And Medical Sciences
(31)
Medical Sciences
(30)
Multiple Myeloma
(29)
Multiple Myeloma - Metabolism
(28)
Oncology
(23)
Cell Line, Tumor
(21)
Female
(21)
Immunopathology
(20)
Immunodeficiencies. Immunoglobulinopathies
(19)
Immunoglobulinopathies
(19)
Male
(18)
Tumor Cells, Cultured
(18)
Cell Biology
(17)
Middle Aged
(16)
Hematologic And Hematopoietic Diseases
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(30)
European Journal Of Haematology
(13)
Tidsskrift For Den Norske Lægeforening
(7)
British Journal Of Haematology
(6)
Haematologica
(6)
Oncotarget
(6)
Cancer Research
(4)
Medical Oncology
(4)
The Journal Of Biological Chemistry
(3)
Cytokine
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protein tyrosine phosphatases in multiple myeloma

Tumour-agnostic drugs and future cancer treatment

Why do myeloma patients have bone disease? A historical perspective

Phosphatase of regenerating liver‐3 regulates cancer cell metabolism in multiple myeloma

Monitoring multiple myeloma by quantification of recurrent mutations in serum

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer

Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells

Markers of endothelial glycocalyx dysfunction in Clarkson disease

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions

PRL‐3 induces a positive signaling circuit between glycolysis and activation of STAT1/2

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3

Bronchoalveolar Lavage Fluid IFN-γ^+ Th17 Cells and Regulatory T Cells in Pulmonary Sarcoidosis

Anti-c-MET Nanobody® - a new potential drug in multiple myeloma treatment

Targeting phosphoglycerate dehydrogenase in multiple myeloma

Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma

Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

VOLIN and KJON-Two novel hyperdiploid myeloma cell lines

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance

Suchergebnisse filtern